Abstract

Acute respiratory illnesses (ARIs) are usually viral [influenza, respiratory syncytial virus (RSV)] and account for 25% of emergency department (ED) peak-season visits. Laboratory PCR testing is accurate albeit slow, whereas rapid antigen testing is inaccurate. We determined the impact of bedside PCR (molecular point-of-care test; mPOCT) on pediatric ARI management. This was a prospective cohort study of consecutive pediatric patients with ED-ordered respiratory PCR test, enrolled over 9 weeks during peak flu season. On ordering, ED physicians were interviewed to ascertain real-time plans if given immediate influenza/RSV PCR results for the current patient. Two groups were compared: actual management and management adjusted for mPOCT results. We compared ED length of stay (LOS), tests ordered, and antibiotic/antiviral ordering. One-hundred thirty-six respiratory PCR panels were ordered, 71 by admitting team, 61 for ED management. Of 61 ED-initiated tests, physicians indicated in 39 cases (64%) they would change patient management were bedside viral results available. Physicians would have decreased ED LOS by 33 minutes, ordered fewer tests (18%; P�<�0.001) with average patient charge savings of $669, fewer antibiotics among discharged patients (17%; P�=�0.043), and increased appropriate antiviral use (13%; P�=�0.023). Rapid bedside ARI mPOCT PCR has the potential to decrease ED LOS, reduce diagnostic tests and patient charges, and increase appropriate use of antibiotics and antiviral agents.

View details for DOI 10.1016/j.jmoldx.2017.01.009

View details for Web of Science ID 000400314100011

View details for PubMedID 28341587

View details for PubMedCentralID PMC5417039

School of Medicine

Showing 1-2 of 2 Results

Allison Katherine Roe

Postdoctoral Medical Fellow, Orthopedic Surgery

Daniel Rogan

Affiliate, Dean's Office Operations - Dean Other

You are Here:

Current Tab: 6

Site Navigation:

Footer Links:

Stanford Medicine Resources: